Cannabis is a pharmacologically rich plant source with many potential medical and recreational applications.
CannRx’s mission is to develop scientifically-based proprietary cannabis technologies and reliable, repeatable, and efficacy driven products using research and leveraging our staff’s scientific expertise.
Maximizing the benefits that cannabis provides requires sophisticated knowledge to:
It is important to understand that the required (or desired) active compounds vary with the specific indication. The active compounds in a cannabis sleep product will be different from those in an epilepsy product, and both will be different from those in a pain product. That is why CannRx considers and analyzes a wide range of cannabinoids, terpenes and other bioactive compounds in its cannabis strains and blends, analyzing and learning the interactions between these compounds.
CannRx is a subsidiary of Izun Pharmaceuticals, a leading company in the boutique pharmaceutical area of Botanical Medicine. Izun has developed extensive technology to analyze plant material and understand the bioactivity of the various compounds found within the plant. Utilizing this technology, Izun can boast of a successful track record in developing breakthrough products in the areas of oral health, oncology support, wound care and women’s health. Izun utilizes the poly-molecular characteristic present in all plants to develop products that are more efficacious than typical single molecule pharmaceutical products. The Izun concept is that all our natural plant products should be “as effective as a drug and as safe as a natural product”.
CannRx is using this technology and know-how to generate more effective, more bioavailable, scientifically formulated cannabis products with precision dosing and predictable therapeutic effects.